Background Although multiple studies have offered self-collection for human papillomavirus (HPV)-based cervical screening in ...
MENLO PARK, Calif., Feb. 3, 2023 /PRNewswire/ -- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback